Improved Data Sharing With International Partners at Core of U.S. FDA Global Plans

Over the next several years, the U.S. Food and Drug Administration (FDA) will engage more with its international counterparts through systems that will allow it to share real-time information and resources in a more comprehensive way than is currently possible. The agency will work with partners to develop better, more systematic ways to share information across borders, according to its “Global Engagement” report, released April 23. It is also looking to identify critical data for risk models and standardize how this information is reported.
International Medical Device Regulatory Monitor